Cargando…
Nasopharyngeal Microbial Communities of Patients Infected With SARS-CoV-2 That Developed COVID-19
BACKGROUND: SARS-CoV-2 is an RNA virus causing COVID-19. The clinical characteristics and epidemiology of COVID-19 have been extensively investigated, however, only one study so far focused on the patient’s nasopharynx microbiota. In this study we investigated the nasopharynx microbial community of...
Autores principales: | Ventero, Maria Paz, Cuadrat, Rafael R. C., Vidal, Inmaculada, Andrade, Bruno G. N., Molina-Pardines, Carmen, Haro-Moreno, Jose M., Coutinho, Felipe H., Merino, Esperanza, Regitano, Luciana C. A., Silveira, Cynthia B., Afli, Haithem, López-Pérez, Mario, Rodríguez, Juan Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010661/ https://www.ncbi.nlm.nih.gov/pubmed/33815323 http://dx.doi.org/10.3389/fmicb.2021.637430 |
Ejemplares similares
-
Putative mobilized colistin resistance genes in the human gut microbiome
por: Andrade, Bruno G. N., et al.
Publicado: (2021) -
Nasopharyngeal Microbiota as an early severity biomarker in COVID-19 hospitalised patients
por: Ventero, Maria Paz, et al.
Publicado: (2022) -
Genomic Characterization of Imipenem- and Imipenem-Relebactam-Resistant Clinical Isolates of Pseudomonas aeruginosa
por: López-Pérez, Mario, et al.
Publicado: (2021) -
Role of Relebactam in the Antibiotic Resistance Acquisition in Pseudomonas aeruginosa: In Vitro Study
por: Ventero, Maria Paz, et al.
Publicado: (2023) -
Impact of Sepsis Flow Chip, a novelty fast microbiology method, in the treatment of bacteremia caused by Gram-negative bacilli
por: Merino, Esperanza, et al.
Publicado: (2021)